Nome Químico: (3RS,5SR,6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate (as per EP);(±)-(3R*,5S*,6E)-7-[3-(p-fluorophenyl)-1-iso propylindol-2-yl]-3,5-dihydroxy-6-heptenoate(as per USP)
Sorrisos: O[C@H](C[C@H](O)CC(O)=O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N1C(C)C
Inchi: InChI=1S/C23H24FNO4/c1-2-25-20-6-4-3-5-19(20)23(15-7-9-16(24)10-8-15)21(25)12-11-17(26)13-18(27)14-22(28)29/h3-12,17-18,26-27H,2,13-14H2,1H3,(H,28,29)/b12-11+/t17-,18-/m1/s1
Improvement of development and validation of an RP-HPLC method for the fluvastatin sodium using QbD approach and its application to forced degradation studies
By Balasaheb, Dhamdhere Rupali; Vijayalakshmi, A.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2020), 11(4), 6938-6948
Method development and validation of Fluvastatin by RP-HPLC
By Monika, Mallepally; Preethi, Ch. Sai; Aruna Rekha, D.; Pandey, Durgesh; Madhuri, G.
From World Journal of Pharmacy and Pharmaceutical Sciences (2020), 9(5), 1342-1351
Development and Validation of Stability-Indicating HPLC Methods for Quantitative Determination of Pravastatin, Fluvastatin, Atorvastatin, and Rosuvastatin in Pharmaceuticals
By Gomes, Fabio Pereira; Garcia, Pedro Lopez; Alves, Joao Marcel Porto; Singh, Anil Kumar; Kedor-Hackmann, Erika Rosa Maria; Santoro, Maria Ines Rocha Miritello
From Analytical Letters (2009), 42(12), 1784-1804